Einride CEO Roozbeh Charli joins 'Squawk Box' to discuss the company's electric and AI-powered freight, why the company is going public now, and more. Coffee linked to significant new side effect, ...

It’s been three-and-a-half years since generative AI exploded onto the scene. In this past year, progress has continued its relentless pace: Vibe coding took off, companies embraced agentic workflows, ...

The plan would give U.S. Citizenship and Immigration Services officers authority to deny asylum applications on the written record if they determine the claims were filed more than one year after the ...

Imagine you have used a generative artificial intelligence (AI) tool such as ChatGPT to tidy up notes you took while in a meeting. Your colleague comments on how clear they are. You don’t disclose it ...

A 4GB file called weights.bin may have appeared on your hard drive, thanks to Chrome. Here's what it is and how to get rid of it. Alex Valdes from Bellevue, Washington has been pumping content into ...

NEW YORK (AP) — The Ebola outbreak in Central Africa could grow to 20,000 cases or more, depending on how quickly infected people are isolated to slow the spread, according to a new analysis by U.S.

The Trump administration on Monday announced it is seeking to revoke the citizenship of 17 U.S. citizens accused of immigration fraud, expanding its unprecedented denaturalization campaign. CBS News ...

West Yorkshire Police (WYP) must improve how it investigates crime after an inspection by the national watchdog identified the force closing cases despite there being potential lines of inquiry. His ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. In this week’s edition of InnovationRx, we look at SpaceX’s hopes for healthcare, the AI ...

Instagram says it has resolved an issue which saw hackers trick its AI support tool into giving them access to other users' accounts. According to claims shown in screenshots and videos shared on ...

Lilly's Jake Van Naarden is meeting myeloma experts at ASCO to figure out the best possible path for phase 3 trials of Kelonia's in vivo CAR-T prospect. (Darren Incorvaia) Kelonia Therapeutics has ...